Vaccine News and Research

Latest Vaccine News and Research

Sinovac Biotech signs marketing agreement with Boryung Pharmaceutical Company

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac's H1N1 vaccine.

3 Sep 2009

National Cancer Institute awards grant to Receptor Logic for breast cancer research

Receptor Logic, Inc. announced today receipt of a Phase I Small Business Technology Transfer (STTR) Grant from the National Cancer Institute. The grant, entitled “Therapeutic Effectiveness of T-Cell Receptor mimic (TCRm™) Antibodies in Breast Cancer Treatment” will accelerate Investigational New Drug Application enabling studies surrounding lead candidate TCRm antibodies.

3 Sep 2009

Health systems, HIV/AIDS, malaria discussed at WHO Regional Committee meeting

Luis Gomes Sambo, WHO regional director for Africa, on Tuesday at the 59th session of the WHO Regional Committee for Africa in Kigali, Rwanda, presented a nine-point guide suggesting malaria control strategies for African countries, Agencia AngolaPress reports. Suggested approaches include updating policies and strategic plans, strengthening research and scaling up supplies of medicines (9/1).

3 Sep 2009

New York Times examines efforts to stop spread of dengue in Asia

"While emerging diseases like influenza A(H1N1), also known as swine flu, continue to dominate the headlines, experts say dengue is not only thriving in many endemic areas, it is also spreading to countries previously unaffected by the disease," New York Times writes.

3 Sep 2009

Obama urges Americans to take precautions to protect themselves from H1N1

After a day of meetings with senior White House officials to discuss the U.S. preparations for H1N1 (swine) flu Tuesday, President Obama urged Americans to take the proper precautions to protect themselves from infection, the Associated Press/Boston Herald reports (9/1).

3 Sep 2009

Hong Kong's healthcare workers to refuse H1N1 vaccine, says study

According to a study released August 26, 2009 by the British Medical Journal, more than half of Hong Kong's healthcare workers surveyed said they would refuse the H1N1 shot, which is not yet available, because they are afraid of side effects and doubt how safe and effective it will be. More importantly, the study suggested the trend would be repeated worldwide.

3 Sep 2009

Also in global health news: Vietnam PEPFAR funding; remote village health care; HIV in India; UNICEF budget; mapping drug shortages

PEPFAR will continue to fund HIV/AIDS programs in Vietnam, Hoang Thanh Hai, a spokesperson, said on Tuesday at a memorial for 100 people who died as a result of complications from the disease, Bernama reports. "Since 2004, PEPFAR has provided $320 million to help Vietnam provide comprehensive services on taking precautionary measures against the disease and care and treatment of HIV" patients, the news service writes (9/2).

3 Sep 2009

Linkwell concerned with misunderstanding of prevention and control measures of H1N1

Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, put forward its worries about the trend of the misunderstanding concerning dealing with the spread of H1N1.

2 Sep 2009

Induced antibodies neutralize HIV-1; recognize peptides encapsulated in liposomes

For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids. The results were reported by U.S. Military HIV Research Program (MHRP) researchers on Aug. 25 in the online version of AIDS, the official journal of the International AIDS Society.

2 Sep 2009

Members of Independence Blue Cross will receive coverage for the administration costs of the H1N1 vaccine

In an effort to help keep members healthy and flu-free this year, Independence Blue Cross (IBC) will offer coverage for the administration costs of the H1N1 (swine flu) vaccine when it becomes available. In addition IBC will continue to cover seasonal flu vaccine.

2 Sep 2009

HAPPYBABY guide for new and expectant parents focuses on green parenting

Green parenting -- more than just a trendy movement -- is the best way to raise healthy babies with lasting results. Parents today feel overwhelmed by all the choices and conflicting information when starting a family.

2 Sep 2009

Health care providers can register online for H1N1 influenza vaccines

Health care providers may now pre-register online if they are interested in receiving pandemic H1N1 influenza vaccines and supplies when those materials become available, the Pennsylvania Department of Health said today.

2 Sep 2009

Single-dose H1N1 vaccine wins approval in China

The Chinese biopharmaceutical company Sinovac Biotech Ltd. on Monday announced its H1N1 (swine) flu vaccine won the approval of a panel of experts from China's State Food and Drug Administration, the Associated Press/Forbes reports. The company expects to obtain a production license later this week. According to the company, clinical trials of the H1N1 vaccine showed a single shot produced an immune response capable of protecting against H1N1 (8/31).

2 Sep 2009

Condoms reduce risk of herpes simplex virus 2

Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

2 Sep 2009

TeleForum to discuss H1N1 precautions on campus

In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.

2 Sep 2009

Despite financial crisis, Africa must focus on health, Rwandan President says at WHO regional meeting

Rwandan President Paul Kagame at the opening of the 59th Session of the WHO Regional Committee for Africa in Kigali, Rwanda, urged delegates from across the continent to focus on promoting health, New Times/allAfrica.com reports (Nambi, 8/31).

2 Sep 2009

H1N1 flu vaccine forms processing service launched by Quality Associates

Quality Associates, Inc. (QAI) www.qualityassociatesinc.com, an established provider of services and solutions for large-scale document management, imaging, and archiving, announced the launch of its H1N1 Flu Vaccine Forms Processing Service, a comprehensive approach to help states, cities, counties, and providers in the private sector successfully and accurately capture and record essential demographic and health data from medical consent forms – a critical step in the administration of the H1N1 vaccine to millions nationwide beginning this fall.

1 Sep 2009

Bio-Matrix Scientific Group's new opportunities in cancer treatment and intellectual property discussed

Bio-Matrix Scientific Group, Inc. Chairman & CEO David Koos commented on the Company’s new opportunities in stem cell research, cancer treatment and intellectual property.

1 Sep 2009

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

A team of researchers from The Wistar Institute have shown that a large non-coding RNA in mammals and yeast plays a central role in helping maintain telomeres, the tips of chromosomes that contain important genetic information and help regulate cell division. Since this RNA also facilitates the formation of DNA at telomeres-a process that can protect aging cells and destabilize tumor cells-manipulating its expression may be useful in treating cancer and other diseases.

1 Sep 2009

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barr- syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and U. S. Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).

1 Sep 2009

Vaccine News and Research

Latest Vaccine News and Research

Sinovac Biotech signs marketing agreement with Boryung Pharmaceutical Company

National Cancer Institute awards grant to Receptor Logic for breast cancer research

Health systems, HIV/AIDS, malaria discussed at WHO Regional Committee meeting

New York Times examines efforts to stop spread of dengue in Asia

Obama urges Americans to take precautions to protect themselves from H1N1

Hong Kong's healthcare workers to refuse H1N1 vaccine, says study

Also in global health news: Vietnam PEPFAR funding; remote village health care; HIV in India; UNICEF budget; mapping drug shortages

Linkwell concerned with misunderstanding of prevention and control measures of H1N1

Induced antibodies neutralize HIV-1; recognize peptides encapsulated in liposomes

Members of Independence Blue Cross will receive coverage for the administration costs of the H1N1 vaccine

HAPPYBABY guide for new and expectant parents focuses on green parenting

Health care providers can register online for H1N1 influenza vaccines

Single-dose H1N1 vaccine wins approval in China

Condoms reduce risk of herpes simplex virus 2

TeleForum to discuss H1N1 precautions on campus

Despite financial crisis, Africa must focus on health, Rwandan President says at WHO regional meeting

H1N1 flu vaccine forms processing service launched by Quality Associates

Bio-Matrix Scientific Group's new opportunities in cancer treatment and intellectual property discussed

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in